Senators Question FDA Nominee Overton as Agency Issues New Rule to Cut Animal Testing

Senators on the Senate Health Committee interrogated President Trump's nominee to lead the FDA, Dr. Janet Overton, during her confirmation hearing. Lawmakers focused on her views about the agency's regulatory priorities and her plans for overseeing drug and device approvals.

At the same time, the FDA released a proposed rule aimed at reducing the use of animals in testing. The rule outlines alternatives and encourages the adoption of modern, non‑animal methods where scientifically valid.

The hearing and the animal‑testing rule highlight the agency's ongoing efforts to balance rigorous safety standards with evolving scientific practices, signaling potential shifts in how future products may be evaluated.